These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19013327)

  • 1. Antiretroviral nephrotoxicities.
    Atta MG; Deray G; Lucas GM
    Semin Nephrol; 2008 Nov; 28(6):563-75. PubMed ID: 19013327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity.
    Jung O; Bickel M; Ditting T; Rickerts V; Welk T; Helm EB; Staszewski S; Geiger H
    Nephrol Dial Transplant; 2004 Sep; 19(9):2250-8. PubMed ID: 15238630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicities of antiretroviral therapy in children.
    Nwaobasi E; Oleske JM
    AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection in older adults.
    Luther VP; Wilkin AM
    Clin Geriatr Med; 2007 Aug; 23(3):567-83, vii. PubMed ID: 17631234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity as a complication of antiretroviral therapy.
    Valle R; Haragsim L
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):314-9. PubMed ID: 16815236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists.
    Berns JS; Kasbekar N
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):117-29. PubMed ID: 17699198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral induced adverse drug reactions in Iranian human immunodeficiency virus positive patients.
    Khalili H; Dashti-Khavidaki S; Mohraz M; Etghani A; Almasi F
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):848-57. PubMed ID: 19551698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of common chronic metabolic complications in HIV-infected patients.
    Bader MS; Kelly DV
    Postgrad Med; 2008 Nov; 120(4):17-27. PubMed ID: 19020362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus and atherosclerosis.
    Farrugia PM; Lucariello R; Coppola JT
    Cardiol Rev; 2009; 17(5):211-5. PubMed ID: 19690471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy: a primer for dermatologists.
    Kim HN; Harrington RD
    Dermatol Clin; 2006 Oct; 24(4):537-47, vii. PubMed ID: 17010782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute kidney injury in patients with human immunodeficiency virus infection.
    Cohen SD; Chawla LS; Kimmel PL
    Curr Opin Crit Care; 2008 Dec; 14(6):647-53. PubMed ID: 19005305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous drug reactions associated with newer antiretroviral agents.
    Martins CR
    J Drugs Dermatol; 2006; 5(10):976-82. PubMed ID: 17373147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated nephropathy in the era of antiretroviral therapy.
    Wyatt CM; Klotman PE
    Am J Med; 2007 Jun; 120(6):488-92. PubMed ID: 17524746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
    Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
    Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.
    Aberg JA; Kaplan JE; Libman H; Emmanuel P; Anderson JR; Stone VE; Oleske JM; Currier JS; Gallant JE;
    Clin Infect Dis; 2009 Sep; 49(5):651-81. PubMed ID: 19640227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy and the prevalence and incidence of diabetes.
    Mikhail N; Cope D
    Arch Intern Med; 2005 Nov; 165(21):2536-7; author reply 2537. PubMed ID: 16314552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.